MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

STERIS PLC

Closed

SectorHealthcare

225.39 0.57

Overview

Share price change

24h

Current

Min

222.95

Max

226.67

Key metrics

By Trading Economics

Income

-27M

146M

Sales

110M

1.5B

P/E

Sector Avg

36.654

39.857

EPS

2.74

Dividend yield

0.95

Profit margin

9.892

Employees

17,787

EBITDA

-37M

337M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+19.03% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.95%

2.42%

Next Earnings

5 sie 2025

Next Dividend date

19 wrz 2025

Next Ex Dividend date

4 wrz 2025

Market Stats

By TradingEconomics

Market Cap

-691M

22B

Previous open

224.82

Previous close

225.39

News Sentiment

By Acuity

76%

24%

347 / 376 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

STERIS PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 maj 2025, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 maj 2025, 20:30 UTC

Earnings

Steris 4Q Rev $1.5B >STE

14 maj 2025, 20:30 UTC

Earnings

Steris 4Q Adj EPS $2.74 >STE

5 lut 2025, 21:35 UTC

Earnings

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 lut 2025, 21:34 UTC

Earnings

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 lut 2025, 21:34 UTC

Earnings

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 lut 2025, 21:33 UTC

Earnings

Steris 3Q EPS $1.75 >STE

5 lut 2025, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 lut 2025, 21:30 UTC

Earnings

Steris 3Q Rev $1.4B >STE

5 lut 2025, 21:30 UTC

Earnings

Steris 3Q Adj EPS $2.32 >STE

6 lis 2024, 21:41 UTC

Earnings

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 lis 2024, 21:40 UTC

Earnings

Steris 2Q EPS $1.51 >STE

6 lis 2024, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 lis 2024, 21:30 UTC

Earnings

Steris 2Q Adj EPS $2.14 >STE

6 lis 2024, 21:30 UTC

Earnings

Steris 2Q Rev $1.3B >STE

6 sie 2024, 20:36 UTC

Earnings

Steris 1Q Adj EPS $2.03 >STE

6 sie 2024, 20:30 UTC

Earnings

Steris 1Q Net $139.9M >STE

6 sie 2024, 20:30 UTC

Earnings

Steris 1Q EPS $1.41 >STE

6 sie 2024, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

Peer Comparison

Price change

STERIS PLC Forecast

Price Target

By TipRanks

19.03% upside

12 Months Forecast

Average 268.5 USD  19.03%

High 280 USD

Low 250 USD

Based on 7 Wall Street analysts offering 12 month price targets forSTERIS PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

5

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

225 / 226.35Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

347 / 376 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.